1. Home
  2. UEC vs KLTOW Comparison

UEC vs KLTOW Comparison

Compare UEC & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uranium Energy Corp.

UEC

Uranium Energy Corp.

HOLD

Current Price

$13.02

Market Cap

6.8B

ML Signal

HOLD

Logo Klotho Neurosciences Inc. Warrant

KLTOW

Klotho Neurosciences Inc. Warrant

HOLD

Current Price

$0.13

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UEC
KLTOW
Founded
2003
N/A
Country
United States
United States
Employees
N/A
3
Industry
Other Metals and Minerals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
N/A
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
UEC
KLTOW
Price
$13.02
$0.13
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$15.80
N/A
AVG Volume (30 Days)
9.2M
N/A
Earning Date
12-10-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$49,750,000.00
N/A
Revenue This Year
$0.59
N/A
Revenue Next Year
$112.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
189.19
N/A
52 Week Low
$3.85
N/A
52 Week High
$17.80
N/A

Technical Indicators

Market Signals
Indicator
UEC
KLTOW
Relative Strength Index (RSI) 49.99 44.16
Support Level $12.52 $0.13
Resistance Level $14.07 $0.15
Average True Range (ATR) 0.93 0.02
MACD 0.18 0.00
Stochastic Oscillator 56.32 11.61

Price Performance

Historical Comparison
UEC
KLTOW

About UEC Uranium Energy Corp.

Uranium Energy Corp is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The Company operates through multiple segments, including uranium mining activities in Wyoming, Texas, Saskatchewan, and other regions, along with a corporate segment focused on investments and uranium inventory trading. It is expanding its portfolio of low-cost uranium projects in stable North American locations and operates a Wyoming-based ISR (In-Situ Recovery) Hub and Spoke platform. This platform is supported by two fully operational central processing plants and seven U.S. ISR uranium projects.

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: